About Kamada
Kamada is a publicly listed company based in Rehovot (Israel) founded in 1990. Specialty biopharmaceutical therapeutics are developed from human plasma proteins. The company has 420 employees. Its website kamada.com draws about 10 thousand monthly visits. Its focus areas include Diversified Pharmaceuticals.
Company details
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique protein purification technology. It uses proprietary technology to extract protein from human plasma to produce alpha-1 antitrypsin (AAT) known to have therapeutic effects. It has a portfolio of 18 products in categories of lung disease, immunoglobins and critical care. It also has a pipeline of 8 compounds in various stages of clinical trial for diseases like AAT deficiency, graft vs host disease (GVHD) etc among others
- Headquarters Rehovot, Israel
- Employees 420
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website kamada.com
- Social LinkedIn YouTube
- Legal Name Kamada Ltd.
- Annual Revenue$195.34 M (USD)19.46as on Dec 31, 2025
- Net Profit$21.86 M (USD)48.81as on Dec 31, 2025
- EBITDA$44.54 M (USD)29.45as on Dec 31, 2025
- Latest Funding Round$25M (USD), Post-IPO
Jan 2020
- InvestorsFIMI Opportunity Funds
& 1 more
- Employee Count420
Apps and channels of Kamada
its YouTube channel Kamada Pharmaceuticals has 85 subscribers and 7 videos.
Videos from Kamada
The most watched videos on Kamada's YouTube channel, Kamada Pharmaceuticals (85 subscribers). Click a video to play it here.
More on Kamada Pharmaceuticals.
Funding Insights of Kamada
- Total Rounds 3
- Last Round Post-IPO — $25M
- First Round $752,612
(Aug 2008)
- Investors Count 2
All 3 funding rounds of Kamada with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2020 | $25M | Post-IPO | – | – | |
| Sep 2017 | $11.29M | Post-IPO | – | – | – |
| Aug 2008 | $752,612 | Post-IPO | – | – |
2 investors in total: 2 institutional.
Investors in Kamada
Kamada has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include FIMI Opportunity Funds and GlenRock Israel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth equity is provided to industrial sector companies by FIMI. | fimi.co.il | Tel Aviv, Israel | ||
Private equity investments are targeted in Israel and the US. | grg.co.il | Herzliya, Israel |
Investor details for Kamada
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Kamada
72 people are tracked at Kamada (32 in leadership, 8 in board & advisors, 32 in team); the tracked headcount is 420.
| Name | Role | Group |
|---|---|---|
Gil Korner | Director Process And Analytical R&d | Leadership |
Tamar Auerbach-Nevo | Director, Head Of Innovation | Leadership |
Jon Knight | Vice President, US Commercial Operations | Leadership |
Nir Livneh | Vp, General Counsel And Corporate Secretary | Leadership |
Sharon Gai-Castro | Head Of Clinical Trials Department | Leadership |
Ronit Geva | Human Resources Director | Leadership |
Ido Feldberg | Production Director | Leadership |
Liron Reshef | VP Human Resources | Leadership |
Yael Brenner | VP Quality | Leadership |
Michal Ayalon | VP Research and Development | Leadership |
Amir London | CEO | Leadership |
Hanni Neheman | VP Marketing & Sales | Leadership |
Roman Elokim | Head Of Control, Training And Planning Team, Plant Engineering | Leadership |
Naveh Tov | VP, Clinical Development and Medical Director for Pulmonary Diseases | Leadership |
Chaime Orlev | CFO | Leadership |
Eran Nir | Chief Operating Officer | Leadership |
Ariella Raban | Vice President, Human Resources | Leadership |
Orna Altman | Director Of Business Excellance | Leadership |
Moshit Tuval | Human Resources Director | Leadership |
Bar Lavi | QA CMO Professional Leader | Leadership |
52 more people are available in the full profile.
Complete people profiles for Kamada
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Kamada
Kamada is a publicly listed company on the NASDAQ with ticker symbol KMDA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date04 Feb 2014
- Listed onNASDAQ: KMDA
- Listed entityKamada Ltd.
- Exchange sectorHealth technology
- ISINIL0010941198
- Share price$7.69 (-1.91% on the day) · 2026-10-13
- Market capitalisation$443.7M
- Price to earnings19.2
- EPS (diluted, trailing year)$0.40
- Dividend yield5.39%
- Volume (last session)87,325
Financials of Kamada
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $195.3M | $21.9M | $44.5M |
| 2024 | $163.5M | $14.7M | $34.4M |
| 2023 | $144.8M | $8.4M | $24.1M |
| 2022 | $123.5M | -$2.2M | $16.8M |
| 2021 | $107.7M | -$2.3M | $5.9M |
Detailed financial statements for Kamada
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Kamada
4 dated milestones of Kamada across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Kamada is founded.
- Funding First funding round of $753K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $25.0M.
Web traffic of Kamada
The website of Kamada (kamada.com) receives about 10.4K visits a month and ranks #2,182,321 among all websites worldwide, #2,963 in Biotechnology and Pharmaceuticals.
- Monthly visits10.4K
- Unique visitors4.5K
per month
- Global rank#2,182,321
among all websites
- Category rank#2,963
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit1.8
- Average visit38 sec
- DevicesDesktop 29% · Mobile 71%
Websites whose visitors overlap most with Kamada. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
quigleyco.com | quigleyco.com | 100% | – | ||
| cslbehring.com | 94% | 78.2K | #544,483 | View details | |
| crescendobiologics.com | 89% | #13,705,548 | View details | ||
| emisphere.com | 88% | View details | |||
| globequimica.com.br | 88% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Kamada
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kamada
Complete news archive for Kamada
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kamada
Kamada was founded in 1990 and raised its 1st funding round 18 years after it was founded.
Kamada is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
Kamada has 420 employees.
Annual revenue of Kamada is $195.34M as on Dec 31, 2025.
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique protein purification technology. It uses proprietary technology to extract protein from human plasma to produce alpha-1 antitrypsin (AAT) known to have therapeutic effects. It has a portfolio of 18 products in categories of lung disease, immunoglobins and critical care. It also has a pipeline of 8 compounds in various stages of clinical trial for diseases like AAT deficiency, graft vs host disease (GVHD) etc among others.
Yes, Kamada is publicly traded on NASDAQ under the ticker symbol KMDA.
Kamada has 2 investors. Key investors include FIMI Opportunity Funds, and GlenRock Israel.